Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | GGT1 | P19440 | 1/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12006238 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL5803387 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL11708028 | 0.84 | ALDH1A1 (0.33) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL2886844 | 0.76 | ODC1 (0.40) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL27967649 | 0.76 | CTSK (0.39) | ALDH1A1MEN1KMT2ALMNAHSD17B10 | |
| SCHEMBL30496170 | 0.76 | ARG1 (0.31) | ARG1ARG2 | |
| SCHEMBL28844285 | 0.75 | ALDH1A1 (0.39) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL11589563 | 0.74 | ALDH1A1 (0.51) | ALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL8709507 | 0.73 | FDPS (0.36) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL11412698 | 0.73 | LMNA (0.39) | ALDH1A1CYP1A2FDPSLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0858794-B1 | Hair care products | KAO CORP (JP) | 2009-08-05 | — | — | EP | disclosed |
| EP-0673647-B1 | Dermatological composition containing lactic acid salt | BRISTOL MYERS SQUIBB CO (US) | 1999-02-17 | — | — | EP | disclosed |
| EP-0673648-B1 | Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate | BRISTOL MYERS SQUIBB CO (US) | 1998-11-25 | — | — | EP | disclosed |
| EP-0858794-A2 | Hair care products | KAO CORPORATION (JP) | 1998-08-19 | — | — | EP | disclosed |
| US-5705168-A | LACTIC ACID FOR SKIN DISORDERS | BRISTOL-MYERS, SQUIBB COMPANY (US) | 1998-01-06 | — | — | US | disclosed |
| US-5702711-A | AS INORGANIC OR ORGANIC LACTATE SALT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0673647-A1 | Dermatological composition containing lactic acid salt | Bristol-Myers Squibb Company (US) | 1995-09-27 | — | — | EP | disclosed |
| EP-0673648-A1 | Compositions comprising amphotoic salts of alpha-hydroxy acids and glycerol monocaprylate | Bristol-Myers Squibb Company (US) | 1995-09-27 | — | — | EP | disclosed |
| US-5420106-A | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-05-30 | — | — | US | disclosed |